Stock Taper 
| DATE | TYPE | RATIO |
|---|---|---|
| 2012-07-17 | Reverse | 1:12 |
DHT Holdings, Inc. owns and operates a fleet of 26 crude oil tankers totaling over 8 million deadweight tons, primarily based in Monaco, Singapore, and Norway, and is headquartered in Hamilton, Bermuda.
DHT Holdings provides crude oil transportation via VLCCs, including their upcoming 'Super Eco-design' vessels, built for 2026 with enhanced fuel efficiency, Tier III compliance, and multi-fuel capability.
In late December 2025, DHT Holdings announced the sale of two of its older VLCCs, the DHT China and the DHT Europe, for a combined price of $101.6 million. This strategic move is expected to generate net cash proceeds of approximately $95.0 million and substantial book gains, signaling a move towards fleet modernization and generating significant investor interest.
DHT Holdings announced a significant capital allocation towards fleet modernization by securing a $308.4 million senior secured credit facility. This financing is dedicated to four newbuild Very Large Crude Carriers (VLCCs) that are scheduled for delivery in the first half of 2026, a move that will enhance the company's earnings power and service offerings. [7, 18]
Corient Private Wealth LP cut its stake in DHT Holdings, Inc. (NYSE: DHT) by 61.7% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 15,707 shares of the shipping company's stock after selling 25,303 shares during the quarter. Corient Private Wealth
Dividend-paying stocks, especially low-priced high-yield 'Dividend Dogs,' offer historically superior risk-adjusted returns and are currently undervalued relative to growth stocks. Analyst projections for the top ten LoPrice/HiYield Dogs suggest average net gains of 50.29% by September 2027, with individual upside estimates up to 65.24%. Twenty-four of thirty-eight highlighted stocks show 'safer' dividends supported by free cash flow, while fourteen rely on borrowed funds for payouts, signaling heightened risk.
Overall rating: A
| PEER | PRICE | |
|---|---|---|
 SM | $35.24 | COMPARE |
 INSW | $115.81 | COMPARE |
 TRMD | $40.00 | COMPARE |
 TNK | $103.10 | COMPARE |
 BTE | $4.63 | COMPARE |
 DKL | $54.93 | COMPARE |
 SDRL | $43.85 | COMPARE |
 NOG | $23.83 | COMPARE |
